Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative FOLFOX4 and Short-course Radiotherapy in Locally Advanced Rectal Cancer
NCT02941562Phase 2Unknown
- Sponsor
- Xinhua Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin, fluorouracil and folinic acid in rectal cancer (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Pathological Tumor Response. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02941562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941562.